You are here:
Invited presentation entitled Approaches to Advance the Application of Novel Approach Methods (NAMs) in Evidence Integration for Risk Assessment of Inhaled Agents at the 23rd Congress of the International Society of Aerosols in Medicine (ISAM)
Citation:
Jarabek, A. Invited presentation entitled Approaches to Advance the Application of Novel Approach Methods (NAMs) in Evidence Integration for Risk Assessment of Inhaled Agents at the 23rd Congress of the International Society of Aerosols in Medicine (ISAM). 23rd Congress of the International Society of Aerosols in Medicine (ISAM), Boise and virtual, ID, May 22 - 26, 2021.
Impact/Purpose:
Invited presentation entitled "Approaches to Advance the Application of Novel Approach Methods (NAMs) in Evidence Integration for Risk Assessment of Inhaled Agents" to be made in a Workshop on the Safety Evaluation of Inhaled Drugs at the 23rd Congress of the International Society of Aerosols in Medicine (ISAM). It will provide technology transfer of EPA work to FDA and pharmaceutical arenas that attend this meeting and provide guiance on the incorporation of novel approach methods (NAMs) into risk assessment for inhaled agents.
Description:
Invited presentation entitled "Approaches to Advance the Application of Novel Approach Methods (NAMs) in Evidence Integration for Risk Assessment of Inhaled Agents" to be made in a Workshop on the Safety Evaluation of Inhaled Drugs at the 23rd Congress of the International Society of Aerosols in Medicine (ISAM). It will provide technology transfer of EPA work to FDA and pharmaceutical arenas that attend this meeting and provide guiance on the incorporation of novel approach methods (NAMs) into risk assessment for inhaled agents.